Palisade Bio

(NASDAQ) PALI

Current Price$1.70

Market Cap$296.82M

Since IPO (2021)-100%

5 Year-100%

1 Year+148%

1 Month-9%

Palisade Bio Financials at a Glance

Market Cap

$296.82M

Revenue (TTM)

$0.00

Net Income (TTM)

-$24.15M

EPS (TTM)

-$1.07

P/E Ratio

-1.60

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$1.70

Volume

2,182,042.458

Open

$1.78

Price

$1.70

Volume

2,182,042.458

Open

$1.78

Previous Close

$1.71

Daily Range

$1.69 - $1.81

52-Week Range

$0.53 - $2.86

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$1.70

Volume

2,182,042.458

Open

$1.78

Previous Close

$1.71

Daily Range

$1.69 - $1.81

52-Week Range

$0.53 - $2.86

Estimated Earnings Date

Aug 10, 2026

PALI News

No articles available.

PALI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Palisade Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

J. D. Finley

Website

www.palisadebio.com

Headquarters

Carlsbad, CA 92008, US

PALI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-36%

Return on Capital

-21%

Return on Assets

-18%

Earnings Yield

-62.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$296.82M

Shares Outstanding

173.58M

Volume

2.18M

Avg. Volume

3.67M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$18.06M

EBITDA

-$16.77M

Operating Cash Flow

-$10.85M

Capital Expenditure

$0.00

Free Cash Flow

-$10.85M

Cash & ST Invst.

$133.39M

Total Debt

$71.00K

Palisade Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$296.82M

N/A

Market Cap/Employee

$37.10M

N/A

Employees

N/A

Net Income

-$9.60M

-330.5%

EBITDA

-$9.60M

-330.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$132.63M

+1734.4%

Total Debt

$0.00

-100.0%

Accounts Receivable

$9.00K

-88.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-18.12%

N/A

Return on Invested Capital

-20.75%

N/A

Free Cash Flow

-$3.89M

-66.7%

Operating Cash Flow

-$3.89M

-66.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LPTXLeap Therapeutics, Inc.

LPTXLeap Therapeutics, Inc.$0.77-3.15%

ATHAAthira Pharma, Inc.

ATHAAthira Pharma, Inc.$6.75-6.12%

DAREDaré Bioscience, Inc.

DAREDaré Bioscience, Inc.$2.02-0.49%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

CTXRCitius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.$0.54-5.69%

CRISCuris, Inc.

CRISCuris, Inc.$0.42-1.29%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$2.77+1.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About PALI

What is the current price of Palisade Bio?

Palisade Bio is trading at $1.71 per share.

What is the 52-week range for Palisade Bio?

Over the past 52 weeks, Palisade Bio has traded between $0.53 and $2.86.

How much debt does Palisade Bio have?

As of the most recent reporting period, Palisade Bio reported total debt of $0.00.

How much cash does Palisade Bio have on hand?

Palisade Bio reported $132.63M in cash and cash equivalents in its most recent financial results.

What is Palisade Bio’s dividend yield?

Palisade Bio does not currently have a dividend yield.

Palisade Bio

Palisade Bio Financials at a Glance

PALI News

PALI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Palisade Bio

PALI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Palisade Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PALI

What is the current price of Palisade Bio?

What is the 52-week range for Palisade Bio?

How much debt does Palisade Bio have?

How much cash does Palisade Bio have on hand?

What is Palisade Bio’s dividend yield?

Premium Investing Services